S-Network Medical IndexesSM

The S-Network Medical Indexes are designed to serve as fair, impartial and transparent measures of the performance of medical equities. There are currently three indexes in the S-Network Medical Index family:

S-Network Biopharma Merger & Acquisition Index (PBMA)

S-Network Medical Breakthroughs Index (PMBI)

S-Network Healthcare Innovation Index (PHIX)

UNIQUE FUNDAMENTALLY BASED METHODOLOGIES

S-Network Medical Indexes represent breakthroughs in “smart beta” index methodologies. S-Network Medical Indexes apply metrics that are specific to biotechnology and pharmaceuticals and are not applicable to other sectors or industries, resulting in highly idiosyncratic performance characteristics.

PURE PLAY

S-Network Medical Indexes focus on companies that are principally engaged in the US health care sector, with strong emphasis on the dynamic small/mid-capitalization biotechnology segment.

ENTIRELY RULES-BASED

All S-Network Medical Indexes depend on clearly defined rules based methodologies, which are overseen by an impartial Index Committee. No discretion is exercised in compiling the indexes and a pre-defined screening protocol assures a consistent, transparent and arms-length compilation process.